A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of HL217 Eye Drop in Healthy Male Subjects

Clinical trial NCT03650608 · COMPLETED

Trial details

NCT number: NCT03650608
Sponsor: Hanlim Pharm. Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subject

Start date: 2016-08-01
Primary completion: 2017-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.